Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 50.93%386.85M | 68.58%371.14M | 19.90%1.1B | 38.24%331.75M | 32.75%292.28M | 16.94%256.32M | -7.95%220.15M | -37.20%918.5M | -2.36%239.98M | -29.62%220.17M |
| Cost of revenue | 42.78%368.8M | 55.70%356.16M | 19.93%1.09B | 36.03%325.33M | 28.24%279.33M | 17.80%258.3M | -0.71%228.74M | -32.07%906.61M | -0.29%239.16M | -23.58%217.81M |
| Gross profit | 1,010.60%18.05M | 274.49%14.99M | 17.46%13.97M | 688.34%6.43M | 448.01%12.96M | -2,377.50%-1.98M | -197.68%-8.59M | -90.71%11.89M | -86.19%815K | -91.50%2.36M |
| Operating expense | 580.05%11.25M | 395.75%10.72M | -18.05%22.36M | -12.30%10.87M | 88.04%8.01M | 141.04%1.65M | -124.70%-3.62M | -53.18%27.29M | -22.45%12.39M | 581.02%4.26M |
| Selling and administrative expenses | 73.56%17.89M | 43.63%13.3M | 10.54%37.81M | 57.09%10.23M | 3.81%9.66M | 17.35%10.31M | -47.34%9.26M | -25.57%34.21M | -53.62%6.51M | 0.36%9.31M |
| -Selling and marketing expense | 82.09%9.31M | 91.48%7.98M | 24.24%16.13M | 150.28%4.4M | 52.62%4.4M | 39.99%5.11M | -67.14%4.17M | -48.61%12.99M | -81.13%1.76M | -27.05%2.88M |
| -General and administrative expense | 65.16%8.58M | 4.53%5.33M | 2.16%21.68M | 22.66%5.83M | -18.09%5.26M | 1.23%5.19M | 3.75%5.1M | 2.60%21.22M | 0.57%4.75M | 20.71%6.42M |
| Other operating expenses | -68.30%355K | 480.43%1.63M | -46.21%1.29M | -3.10%7.43M | --539K | -72.12%1.12M | 75.63%281K | -87.40%2.39M | 243.67%7.67M | ---- |
| Total other operating income | -28.42%7M | -67.98%4.22M | 79.76%16.74M | 280.07%6.79M | -56.51%2.2M | -41.93%9.77M | 327.78%13.17M | 40.11%9.31M | 124.54%1.79M | -50.29%5.05M |
| Operating profit | 287.02%6.8M | 185.98%4.27M | 45.48%-8.39M | 61.64%-4.44M | 361.49%4.95M | -192.05%-3.64M | 15.52%-4.97M | -122.08%-15.39M | -14.89%-11.57M | -106.59%-1.89M |
| Net non-operating interest income (expenses) | -19.89%-2.94M | -11.14%-3.12M | -11.63%-11.26M | -56.72%-3.43M | 0.07%-2.84M | 4.63%-2.45M | -13.31%-2.81M | -16.35%-10.08M | -91.26%-2.19M | 4.88%-2.84M |
| Non-operating interest income | -50.65%641K | 28.45%605K | -26.15%3.08M | -69.91%309K | 10.02%955K | 27.35%1.3M | -62.29%471K | 39.73%4.16M | -23.64%1.03M | 9.87%868K |
| Non-operating interest expense | -4.53%3.58M | 13.63%3.73M | 0.59%14.33M | 16.27%3.74M | 2.29%3.8M | 4.45%3.75M | -12.02%3.28M | 22.33%14.25M | 29.17%3.22M | -1.80%3.71M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 163.38%3.86M | 114.75%1.15M | 22.88%-19.65M | 42.82%-7.87M | 144.50%2.11M | -541.87%-6.09M | 6.97%-7.77M | -141.72%-25.48M | -22.68%-13.76M | -118.42%-4.74M |
| Income tax | 310.94%3.76M | 280.94%3.34M | -10.37%8.96M | -35.68%4.07M | 193.55%3.09M | -47.05%914K | -0.34%876K | -55.74%9.99M | 281.22%6.33M | -76.57%1.05M |
| Net income | 101.47%103K | 74.68%-2.19M | 19.35%-28.6M | 40.57%-11.94M | 82.97%-986K | -1,912.36%-7M | 6.33%-8.65M | -192.14%-35.47M | -56.02%-20.09M | -127.29%-5.79M |
| Net income continuous operations | 101.47%103K | 74.68%-2.19M | 19.35%-28.6M | 40.57%-11.94M | 82.97%-986K | -1,912.36%-7M | 6.33%-8.65M | -192.14%-35.47M | -56.02%-20.09M | -127.29%-5.79M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 101.47%103K | 74.68%-2.19M | 19.35%-28.6M | 40.57%-11.94M | 82.97%-986K | -1,912.36%-7M | 6.33%-8.65M | -192.14%-35.47M | -56.02%-20.09M | -127.29%-5.79M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 101.47%103K | 74.68%-2.19M | 19.35%-28.6M | 40.57%-11.94M | 82.97%-986K | -1,912.36%-7M | 6.33%-8.65M | -192.14%-35.47M | -56.02%-20.09M | -127.29%-5.79M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0 | 74.63%-0.017 | 19.27%-0.222 | 40.59%-0.0925 | 83.07%-0.0076 | -1,907.41%-0.0542 | 6.29%-0.067 | -192.28%-0.275 | -55.86%-0.1557 | -127.31%-0.0449 |
| Diluted earnings per share | 0 | 74.63%-0.017 | 19.27%-0.222 | 40.59%-0.0925 | 83.07%-0.0076 | -1,907.41%-0.0542 | 6.29%-0.067 | -192.28%-0.275 | -55.86%-0.1557 | -127.31%-0.0449 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.